Daftar untuk membuat makluman bagi Instrumen,
Acara Ekonomi dan kandungan berdasarkan penulis yang diikuti
Daftar Percuma Sudah mempunyai akaun? Daftar Masuk
Sebutan
Semua Jenis Instrumen
- Semua Jenis Instrumen
- Indeks
- Ekuiti
- ETF
- Dana
- Komoditi
- Matawang
- Kripto
- Bon
- Sijil
Sila cuba carian lain
📈 Adakah anda akan serius untuk melabur pada tahun 2025? Ambil langkah pertama dengan diskaun 50% untuk InvestingPro
Tuntut Tawaran
Nexpoint Event Driven Fund Class Z (HHCZX)
Tambah kepada/Keluarkan daripada Portfolio
Tambah kepada Portfolio
16.56
-0.05
-0.30%
22/01 - Data Tertunda. Matawang dalam USD
- Penarafan Morningstar:
- Jumlah Aset: 75.71M
Highland Long/Short Healthcare Z
16.56
-0.05
-0.30%
- Tinjauan
- Profil
- Data Sejarah
- Pegangan
Tinjauan HHCZX
Di laman ini anda akan mendapat profil terperinci Nexpoint Event Driven Fund Class Z. Ketahui tentang pengurusan kanan, jumlah aset, strategi pelaburan dan maklumat untuk dihubungi HHCZX antara maklumat lain.
Maklumat Untuk Dihubungi
Alamat
200 Crescent Court, Suite 700
Dallas,TX 75201
United States
Dallas,TX 75201
United States
Telefon
+1 8776651287
Eksekutif Tinggi
| Nama | Tajuk | Sejak | Sehingga |
|---|---|---|---|
| Scott Johnson | Portfolio Manager | 2022 | now |
| Biografi | Mr. Johnson is a Managing Director and Portfolio Manager at NexPoint Advisors, L.P. He has over 25 years of investment management experience with extensive experience in private equity, mergers and acquisitions and long/short hedge funds. Prior to joining NexPoint he was the CEO of Enviroklean Product Development which he purchased along with a private equity group. Previously, Mr. Johnson also held positions as President of Trisun Energy Services and was the Portfolio Manager of the Income Fund, L.P., an investment fund focused on making opportunistic investments in public and private debt and equity securities. Prior to managing the Income Fund, he was a Portfolio Manager at Highland Capital Management, L.P. Prior to joining Highland, Mr. Johnson was an Associate at Wellspring Capital Management, a private equity firm focused on control-oriented buyout investments. Mr. Johnson started his career as an Analyst in the Mergers & Acquisitions group at Lehman Brothers. Mr. Johnson received a B.B.A. in Finance with honors from the University of Texas at Austin and an MBA from Harvard Business School. | ||
| James D. Dondero | President | 2018 | now |
| Biografi | Mr. Dondero is also the co-founder and President of Highland, founder and President of NexPoint Advisors, L.P., Chairman of the board of directors, Chief Executive Officer and member of the investment committee of NXRT, President of NexPoint Capital, Inc., President of NMCT, director for American Banknote Corporation, director for Metro-Goldwyn-Mayer, director for Jernigan Capital, Inc., Chairman of the board of directors for Cornerstone Healthcare, Chairman of the board of directors for CCS Medical, and Chairman of NexBank, an affiliated bank that is majority owned by Mr. Dondero. Mr. Dondero has over 30 years of experience investing in credit and equity markets and has helped pioneer credit asset classes. Prior to founding Highland Capital Management in 1993, Mr. Dondero served as Chief Investment Officer of Protective Life’s GIC subsidiary and helped grow the business between 1989 and 1993. His portfolio management experience includes mortgage-backed securities, investment grade corporates, leveraged bank loans, high-yield bonds, emerging market debt, real estate, derivatives, preferred stocks and common stocks. From 1985 to 1989, he managed in fixed income funds for American Express. Mr. Dondero received a BS in Commerce (Accounting and Finance) from the University of Virginia, and is a Certified Managerial Accountant and a Chartered Financial Analyst. | ||
| Eric Fritz | - | 2021 | 2022 |
| Biografi | Mr. Fritz is an Equity Associate at HCMFA. Prior to joining Highland in July 2013, Mr. Fritz worked as an investment banking analyst for Citigroup Global Markets Inc. (“Citi”). While at Citi, Mr. Fritz advised on and executed capital markets and M&A transactions in the metals & mining, heavy equipment and diversified industrials sectors. Mr. Fritz received a B.B.A. in Finance and Mathematics from the University of Notre Dame. | ||
| Nate Burns | Managing Director | 2019 | 2021 |
| Biografi | Mr. Burns is a Managing Director at HCMLP. Mr. Burns initially joined the Adviser in 2014 as a Director on the absolute return investment team, with responsibility for originating and managing public and private debt and equity investments in the healthcare industry. Prior to joining HCMLP in 2013, he was an Associate at Ripplewood Holdings, a global private equity firm focused on control-oriented buyout, distressed and special situation investments. Prior to joining Ripplewood, he was an Analyst in the Global Technology Mergers & Acquisitions group at Lehman Brothers. Mr. Burns serves on the Board of Directors of Oasis I Limited and Tandem Hospital Partners, LLC. Mr. Burns received a B.S. in Analytical Finance and Economics, summa cum laude, from Wake Forest University and an MBA, with Honors and Distinction, from Columbia Business School. Mr. Burns has also earned the right to use the Chartered Financial Analyst designation. | ||
| Andrew Hilgenbrink | Managing Director | 2018 | 2019 |
| Biografi | Dr. Hilgenbrink is a Managing Director at HCMFA. Prior to his current position he was Director of Investments for an affiliated adviser. Prior to joining HCMFA, Dr. Hilgenbrink was a Director for Cummings Bay’s dedicated healthcare equity funds. Prior to Cummings Bay, he spent four years as a healthcare equity analyst at Jefferies & Company. During his tenure at Jefferies, he covered stocks in a variety of healthcare sectors including specialty pharma, pharmaceutical services, managed care, and healthcare information technology. He has been actively involved in the biotech sector for over seventeen years. This includes pharmaceutical experiences spanning the commercial, research and investment management functions. Dr. Hilgenbrink was a member of the Board of Directors for Molecular Insight Pharmaceuticals prior to its acquisition. Dr. Hilgenbrink holds a Doctorate of Chemistry from Purdue University and a M.B.A. from the Owen Graduate School of Management at Vanderbilt University. He completed his Bachelors of Science degree in Biochemistry from the University of Missouri. | ||
| Michael D. Gregory | Portfolio Manager | 2010 | 2018 |
| Biografi | Michael Gregory is a CIO and Global Head of Highland Alternative Investors at Highland in addition to Managing Director and Head of Healthcare Credit and Healthcare Long/ Short Equity investment strategies. In 2006, he founded Cummings Bay Healthcare Fund, a healthcare hedge fund that is currently in the seventh year of operations and became an affiliate of Highland in 2010. Mr. Gregory also worked as a Partner at Sands Point Capital Management LLC, managing a dedicated healthcare equity hedge fund. Mr. Gregory holds an MBA from the Yale School of Management, having completed a highly specialized joint program in healthcare within the Yale Schools of Medicine, Management and Public Policy. He holds a BS in Economics from the University of Pennsylvania, Wharton School of Business. He is a Fellow of the Royal Society of Medicine, lecturer at Yale University, and frequent guest on CNBC, Fox Business and Morningstar. | ||
| James D. Dondero | President | 2009 | 2010 |
| Biografi | Mr. Dondero is also the co-founder and President of Highland, founder and President of NexPoint Advisors, L.P., Chairman of the board of directors, Chief Executive Officer and member of the investment committee of NXRT, President of NexPoint Capital, Inc., President of NMCT, director for American Banknote Corporation, director for Metro-Goldwyn-Mayer, director for Jernigan Capital, Inc., Chairman of the board of directors for Cornerstone Healthcare, Chairman of the board of directors for CCS Medical, and Chairman of NexBank, an affiliated bank that is majority owned by Mr. Dondero. Mr. Dondero has over 30 years of experience investing in credit and equity markets and has helped pioneer credit asset classes. Prior to founding Highland Capital Management in 1993, Mr. Dondero served as Chief Investment Officer of Protective Life’s GIC subsidiary and helped grow the business between 1989 and 1993. His portfolio management experience includes mortgage-backed securities, investment grade corporates, leveraged bank loans, high-yield bonds, emerging market debt, real estate, derivatives, preferred stocks and common stocks. From 1985 to 1989, he managed in fixed income funds for American Express. Mr. Dondero received a BS in Commerce (Accounting and Finance) from the University of Virginia, and is a Certified Managerial Accountant and a Chartered Financial Analyst. | ||
| Brad Means | Senior Portfolio Manager | 2008 | 2010 |
| Biografi | Means is a Senior Portfolio Manager at Highland Capital Management, L.P. Prior to joining Highland, he was a Managing Director in FTI Consultings Corporate Finance group. From 1998 to 2001, Means was a Director in the PricewaterhouseCoopers Chairmans Office. Prior to this, he worked in the Strategic Change Consulting and the Assurance & Business Advisory groups of Price Waterhouse serving clients. Means holds the Chartered Financial Analyst designation. | ||
| Brad Borud | Partner, Senior Trader, CIO, Co-Director, Portfolio Manager, Head, Portfoli | 2009 | 2009 |
| Biografi | Borud is a Partner, Senior Trader and Chief Investment Officer — Retail Products at Highland Capital Management, L.P. Prior to that, he served as a Senior Trader and Co-Director of Portfolio Management for Highland from 2003 to 2008, as a Portfolio Manager and Team Leader from 2001 to 2003, as a Portfolio Manager from 1998 to 2001, and as a Portfolio Analyst from 1996 to 1998. Prior to joining Highland in November 1996, he worked as a Global Finance Analyst in the Corporate Finance Group from 1995 to 1996. | ||
| Nathan Hukill | - | 2008 | 2009 |
Tulis pendapat anda tentang Nexpoint Event Driven Fund Class Z
Adakah anda pasti anda mahu padamkan carta ini?
Padam Batal
Gantikan carta yang disertakan dengan carta baru?
Ganti Batal
Garis Panduan Komen
Tambah Carta kepada Komen
Sahkan Halangan
Adakah anda pasti anda mahu halang %USER_NAME%?
Dengan berbuat demikian, anda dan %USER_NAME% tidak akan dapat melihat post satu sama lain.
%USER_NAME% telah berjaya ditambah ke Senarai Halangan anda
Oleh kerana anda baru sahaja berhenti halang orang ini, anda perlu menunggu 48 jam sebelum memperbaharui halangan itu.
Laporkan komen ini
Saya berpendapat komen ini:
Komen ditandakan
Thank You!
Laporan anda telah dihantar kepada moderator untuk semakan